Back to mobile site

Echo Therapeutics (ECTE) Tops Q1 EPS by 8c

May 9, 2014 7:51 AM EDT

Echo Therapeutics (NASDAQ: ECTE) reported Q1 EPS of ($0.23), $0.08 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $19.11 thousand versus the consensus estimate of $20 thousand.

For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings